BioSpace News Archive

BrainStorm Cell Therapeutics Inc. announced that final participant dosing has been administered in the Phase 3 pivotal trial of NurOwn® in amyotrophic lateral sclerosis.

Cardinal Health plans to release fourth-quarter and year-end financial results for its fiscal year 2020 on August 6 prior to the opening of trading on the New York Stock Exchange.

Joanne Viney, Ph.D., brings expertise as an immunologist and veteran biotech executive to the board Drs. Luke Evnin and Patrick Baeuerle step down from the Harpoon board Dr. Baeuerle remains as a scientific advisor to the company SOUTH SAN FRANCISCO, Calif., July 02, 2020 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing a novel class of T cell engagers, today announced the appointment of veteran biotech executive Joanne

StageZero Life Sciences (TSX:SZLS) StageZero Life Sciences today announced a corporate update on its business. The Company was pleased to announce earlier this week the closing of the previous announced financing of $4.6 million. The Company will be immediately initiating activities based on the stated Use of Proceeds from the final Prospectus dated June 22, 2020. Specifically hiring staff, and p

BioLife Solutions , Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced the pricing of its public offering of 5,175,000 shares of its common stock at a public offering price of $14.50 per share, before u

Berlin Heart Inc. announced they have completed the Post Approval Surveillance for the EXCOR® Pediatric Ventricular Assist Device, a requirement of the Post Market Approval (PMA) granted by the Food and Drug Administration (FDA), in June 2017

Drs. Rebecca W.

VPR Brands, LP a technology products company is proud to announce its Automated Infrared Body Temperature Screening Device dubbed VPR Verified is now available for resale through industry leading Katom Restaurant Supply, Inc.

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the third quarter of fiscal 2020 on Wednesday, July 29, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. Interested participants may listen to the call by dialing 800-263-0877 (in the United States and Canada) or +1 323-794-2094

Canalevia would be first and only FDA-approved plant-based medicine for working dogs that suffer from diarrhea